Last reviewed · How we verify
Dapagliflozin and Sitagliptin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Dapagliflozin and Sitagliptin (Dapagliflozin and Sitagliptin) — SK Chemicals Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dapagliflozin and Sitagliptin TARGET | Dapagliflozin and Sitagliptin | SK Chemicals Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dapagliflozin and Sitagliptin CI watch — RSS
- Dapagliflozin and Sitagliptin CI watch — Atom
- Dapagliflozin and Sitagliptin CI watch — JSON
- Dapagliflozin and Sitagliptin alone — RSS
Cite this brief
Drug Landscape (2026). Dapagliflozin and Sitagliptin — Competitive Intelligence Brief. https://druglandscape.com/ci/dapagliflozin-and-sitagliptin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab